The Dynamics of Antibody Titres Against SARS-CoV-2 in Vaccinated Healthcare Workers: A Systemic Literature Review
- PMID: 39772080
- PMCID: PMC11680401
- DOI: 10.3390/vaccines12121419
The Dynamics of Antibody Titres Against SARS-CoV-2 in Vaccinated Healthcare Workers: A Systemic Literature Review
Abstract
Background and Objectives: Given that COVID-19 vaccination is a relatively recent development, particularly when compared to immunisation against other diseases, it is crucial to assess its efficacy in vaccinated populations. This literature review analysed studies that monitored antibody titres against SARS-CoV-2 in healthcare workers who received COVID-19 vaccines. Methods: Using the PICO (Population, Intervention, Comparators, Outcomes) model recommended in the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines we included 43 publications which analyse antibody dynamics following primary vaccination, the effects of booster doses, and the influence of factors such as COVID-19C infection, age, and sex on antibody kinetics. Results: All the studies demonstrated a strong immunogenic response to the vaccines. Re-gardless of the vaccine used, over 95% of the pre-vaccination seronegative population be-came seropositive in all studies. Depending on the sampling intervals provided by the re-searchers, antibody levels were quantitatively highest during the first three months after vaccination, but levels inevitably declined over time. The monthly decline in antibodies observed in all these studies highlighted the necessity for booster doses. Studies analysing the impact of revaccination on antibody dynamics have confirmed that revaccination is an effective tool to boost humoral immunity against SARS-CoV-2. An-tibodies appear to persist for a longer period of time after revaccination, although they are subject to similar factors influencing antibody dynamics, such as age, comorbidities, and exposure to COVID-19. In addition, heterogeneous revaccination strategies have been shown to be more effective than homogeneous revaccination. Conclusions: Our review demonstrated that antibody levels against SARS-CoV-2 inevitably decline after vaccination, leaving the question of ongoing booster strategies open. The studies reviewed provided evidence of the effectiveness of booster vaccination, despite differences in age, sex, and prior COVID-19 infection. This suggests that repeated vaccination remains a highly effective method for mitigating the continued threat posed by COVID-19.
Keywords: COVID-19; antibodies; healthcare workers; vaccination.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Follow-up SARS-CoV-2 serological study of a health care worker cohort following COVID-19 booster vaccination.BMC Infect Dis. 2024 Apr 24;24(1):436. doi: 10.1186/s12879-024-09338-5. BMC Infect Dis. 2024. PMID: 38658874 Free PMC article.
-
[COVID-19 infections and effectiveness of the vaccination among healthcare workers].Orv Hetil. 2023 Feb 5;164(5):163-171. doi: 10.1556/650.2023.32709. Print 2023 Feb 5. Orv Hetil. 2023. PMID: 36739547 Hungarian.
-
COVID-19 lateral flow IgG seropositivity and serum neutralising antibody responses after primary and booster vaccinations in Chile: a cross-sectional study.Lancet Microbe. 2023 Mar;4(3):e149-e158. doi: 10.1016/S2666-5247(22)00290-7. Epub 2023 Jan 27. Lancet Microbe. 2023. PMID: 36716754 Free PMC article.
-
The effectiveness of the first dose COVID-19 booster vs. full vaccination to prevent SARS-CoV-2 infection and severe COVID-19 clinical event: a meta-analysis and systematic review of longitudinal studies.Front Public Health. 2023 Jun 1;11:1165611. doi: 10.3389/fpubh.2023.1165611. eCollection 2023. Front Public Health. 2023. PMID: 37325336 Free PMC article.
-
Interventions to increase COVID-19 vaccine uptake: a scoping review.Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD015270. doi: 10.1002/14651858.CD015270. Cochrane Database Syst Rev. 2022. PMID: 35920693 Free PMC article.
References
-
- WHO Coronavirus (COVID-19) Dashboard Overview. [(accessed on 15 September 2024)]. Available online: https://data.who.int/dashboards/covid19/cases?n=c.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous